FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Release Date:

The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.

FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Title
'Mind-blowing' study upends conventional wisdom on oxytocin
Copyright
Release Date

flashback